Surmodics reported $-4937000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 2985M 750M
Align Technology ALGN:US $ 191.46M 36.25M
Arrowhead Research ARWR:US $ -70306000 114.46M
Baxter International BAX:US $ 787M 124M
Bioscrip BIOS:US $ 76.35M 8.12M
Boston Scientific BSX:US $ 648M 407M
Cryolife CRY:US $ 7.06M 1.14M
Edwards Lifesciences EW:US $ 499.7M 19.1M
Haemonetics HAE:US $ 112.29M 46.15M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Johnson & Johnson JNJ:US $ 8036M 1273M
Merit Medical Systems MMSI:US $ 54.18M 16.8M
Mesa Laboratories MLAB:US $ 3.9M 5.38M
Nektar Therapeutics NKTR:US $ -44.27M 67.08M
Stryker SYK:US $ 1156M 144M
Surmodics SRDX:US $ -4.94M 2.36M
Trinity Biotech TRIB:US 873K 928K